Clinical trials
Gastric or Esophagogastric Junction Adenocarcinoma clinical trials
Below are recruiting gastric or esophagogastric junction adenocarcinoma clinical trials, each written for real people, not researchers. We’re tracking 939 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06650332RecruitingPhase 1/Phase 2
Cadonilimab combo for first-line HER2-positive gastric cancer
This trial tests a new combination treatment (cadonilimab plus chemotherapy) as the first therapy for people with advanced gastric or gastroesophageal junction cancer that has a certain amount of HER2 protein. It aims to see if this combination can shrink tumors and help people live longer.
Hangzhou, ZhejiangAges 18–75 - NCT06679244Recruiting
New surgery for upper stomach cancer
This trial tests a new surgical technique for patients with cancer in the upper part of the stomach or where the stomach meets the esophagus. It aims to see if the new approach is safe and effective for removing the tumor and nearby lymph nodes.
ShanghaiAges 18–80 - NCT07708220Recruiting
Laparoscopic treatment for acid reflux in children
This trial tests a minimally invasive surgery to treat gastroesophageal reflux disease (GERD) in children. It aims to reduce symptoms and improve quality of life for kids who have not had prior reflux surgery.
TantaAges 2–18 - NCT06453486RecruitingPhase 2
High dose radiation for pancreatic cancer after chemo
This trial tests whether giving a strong, focused dose of radiation can help people with locally advanced pancreatic cancer that has shrunk or stayed stable with first-line chemotherapy. It aims to improve outcomes for those who cannot have surgery.
Toronto, OntarioAges 18 years+ - NCT07392268Recruiting
Testing AI to help during endoscopic surgery
This trial tests an AI system to help guide doctors during a minimally invasive procedure to remove early-stage lesions in the esophagus, stomach, or colon. If you're scheduled for this surgery, the AI may help make it safer and more precise.
Hong KongAges 18–85 - NCT07312890Recruiting
Ultrasound to check stomach fullness in ICU patients
This trial tests whether a bedside ultrasound can measure how full the stomach is in patients on a breathing machine who are receiving liquid nutrition through a tube. If it works, doctors may avoid complications and feed patients more safely.
LyonAges 18 years+ - NCT06510010RecruitingPhase 2
Chemo plus H. pylori treatment for advanced stomach cancer
This trial tests whether adding H. pylori bacteria treatment to standard chemotherapy (before and after surgery) can improve outcomes for people with locally advanced stomach cancer. It combines oxaliplatin and S-1 chemo with antibiotics to clear the infection.
GuangzhouAges 18–75 - NCT06506292RecruitingPhase 2
Study of adebrelimab plus chemo before and after stomach cancer surgery
This trial tests combining adebrelimab (an immunotherapy) with chemotherapy (XELOX) before and after surgery for stomach cancer that hasn't spread. The goal is to see if this approach helps shrink tumors and improves outcomes.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT05699655RecruitingPhase 2/Phase 3
New pre-surgery treatment for advanced stomach cancer with immunotherapy
This trial tests a new combination (tislelizumab plus apatinib and chemotherapy) before surgery for certain advanced stomach cancers, compared with the standard chemotherapy plus S1. The goal is to shrink the tumor and improve outcomes before and around surgery.
Fuzhou, FujianAges 18–75 - NCT07355374Recruiting
Balloon dilation during esophageal cancer surgery
This trial tests whether expanding a balloon inside the esophagus during keyhole surgery can reduce a serious complication called anastomotic leak. If you have esophageal cancer and are scheduled for a minimally invasive Ivor Lewis esophagectomy, you may be eligible.
Basel, Canton of Basel-CityAges 18 years+ - NCT05762991Recruiting
AI test to help diagnose stomach bacteria and early stomach changes
This trial checks whether an artificial intelligence (computer) system can help diagnose Helicobacter pylori (a common stomach bacteria) and early stomach “premalignant” changes using endoscopy results. It may help doctors spot problems more accurately when you have a scheduled scope.
TaipeiAges 20–80 - NCT07254715RecruitingPhase 4
Itopride for stomach issues from semaglutide in diabetic women
This trial tests if itopride can help with stomach problems caused by semaglutide in diabetic women having a hysterectomy. It aims to see if this combination can improve symptoms like slow stomach emptying.
Cairo, Cairo GovernorateAges 40–60 - NCT07643298Recruiting
Lidocaine through feeding tube to reduce nausea after weight-loss surgery
This study tests whether delivering lidocaine (a numbing medication) through a feeding tube during weight-loss surgery can reduce nausea and vomiting afterward. You would receive this medication as part of the surgery procedure to see if it helps you feel better in recovery.
Yinchuan, NingxiaAges 18–65 - NCT07024615RecruitingPhase 1
Study of ASP2138 before surgery for pancreatic cancer
This study tests an experimental drug, ASP2138, given before surgery for pancreatic cancer that is still removable. After surgery, you will receive standard chemotherapy. The goal is to see if adding ASP2138 before surgery helps improve outcomes.
Boston, MassachusettsAges 18 years+ - NCT07015424Recruiting
TORe procedure vs lifestyle changes for weight regain after bypass
This study compares a procedure called TORe (a way to reduce the size of your stomach opening) combined with lifestyle changes versus lifestyle changes alone to help people who have regained weight after gastric bypass surgery. The goal is to see which approach works better for long-term weight control.
Irvine, CaliforniaAges 18 years+ - NCT06748690Recruiting
Comparing biopsy methods for stomach tumors
This trial compares two ways to take a tissue sample from stomach tumors before surgery to see which works better. The results may help doctors choose the best method for patients.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05838300Recruiting
Compare special air flow methods during gastric bypass surgery
This trial compares two ways of delivering and removing carbon dioxide gas during minimally invasive gastric bypass and related hiatal hernia repair surgery. It looks at whether one method is safer or more comfortable by changing how the gas is warmed, humidified, and controlled.
Houston, TexasAges 18–65 - NCT06941545Recruiting
Stomach mapping study for functional dyspepsia
This study uses a special stomach mapping technique and a tube to measure stomach activity in people with functional dyspepsia (long-term stomach discomfort or pain). The goal is to better understand how the stomach works, which could help improve future treatments.
Rochester, MinnesotaAges 18–80 - NCT07728292Recruiting
Underwater removal of small gastric neuroendocrine tumors
This trial tests a special underwater technique to remove small type I gastric neuroendocrine tumors (5-9 mm) during an endoscopy. The goal is to see if it is safe and effective, which could offer a less invasive treatment option.
Hyderabad, TelanganaAges 18–65 - NCT06627634Recruiting
Surgery for stomach cancer that spread to the liver
This trial tests if removing the stomach tumor and liver spots together can help people with stomach cancer that has spread only to the liver. It is for those who are healthy enough for surgery and chemotherapy.
Aarhus, JyllandAges 18 years+ - NCT06610799RecruitingPhase 1
Study of IBI363 for first-line advanced gastric cancer
This trial tests a new drug called IBI363 in patients with advanced gastric or gastroesophageal junction cancer who have not yet received any treatment. The goal is to see if the drug can help shrink tumors or slow the cancer's growth.
Hangzhou, ZhejiangAges 18–75 - NCT06023758RecruitingPhase 2
Study of two drugs with or without chemo for HER2-positive stomach cancer
This study tests two new immunotherapy drugs (KN026 and KN046) with or without chemotherapy (XELOX) for people with a specific type of advanced stomach cancer that makes too much HER2 protein. The goal is to see if this combination can shrink tumors or slow the cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT05325736Recruiting
Study how bariatric surgery changes blood sugar response
This study looks at how blood sugar responds after bariatric surgery (or related surgery) and whether changes can be measured over time. It may help doctors better understand which people respond best after surgery.
RehovotAges 18–70 - NCT07006142Recruiting
Fasting time and stomach volume for GLP-1 patients
This trial studies how a longer fasting period affects stomach contents in people taking GLP-1 receptor agonists (a type of diabetes or weight-loss drug). It helps doctors understand if extra fasting time is needed before an upper endoscopy (a camera test for the stomach).
Rochester, MinnesotaAges 18 years+
Hear when a new Gastric or Esophagogastric Junction Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastric or esophagogastric junction adenocarcinoma?
- Yes. Clin2 currently lists 939 recruiting gastric or esophagogastric junction adenocarcinoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastric or esophagogastric junction adenocarcinoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastric or esophagogastric junction adenocarcinoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Gastric / Gastroesophageal Junction Adenocarcinoma
- Adenocarcinoma of Esophagogastric Junction
- Gastric or Gastroesophageal Junction Adenocarcinoma
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma
- Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- Siewert Type II Adenocarcinoma of Esophagogastric Junction
- Gastric Adenocarcinoma
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.